LDS/Medical Tests/MSH2 Gene Mutation Analysis (Known Mutations, Duplication/Deletion/Sequencing)

MSH2 Gene Mutation Analysis (Known Mutations, Duplication/Deletion/Sequencing)

The MSH2 gene is located in the short (p) arm of chromosome 2 between positions 21 and 16.3. It encodes the DNA mismatch repair protein Msh2 also known as MutS homolog 2 or MSH2 protein. The MSH2 gene is a member of a set of genes known as the mismatch repair (MMR) genes and plays an essential role in DNA repair. The MSH2 protein forms a protein complex either with MSH6 or MSH3 that identify the location of DNA errors that occur during cell replication. MSH2 is involved in many different forms of DNA repair, including transcription-coupled repair, homologous recombination and base excision repair.

Mutations in the MSH2 gene are associated with Lynch syndrome or hereditary nonpolyposis colon cancer and microsatellite instability. Lynch syndrome is an autosomal dominantly inherited syndrome that is caused by germline mutations in one of the mismatch repair genes, MLH1, MSH2, MSH6, or PMS2. About 40% cases of Lynch syndrome is caused by an inherited mutation in one MSH2 allele. Lynch syndrome is characterized by an increased risk for colorectal cancer (CRC) and cancers of the endometrium, stomach, ovary, small bowel, hepatobiliary tract, urinary tract, brain, and skin. As a general rule, a single inherited mutation is insufficient to cause cancer and inactivation of the second allele by somatic mutation, loss of heterozygosity or epigenetic silencing secondary to promotor hypermethylation.

Lack of a functional MMR gene results in an increased genomic instability particularly in areas of repetitive genetic sequences termed “microsatellites”. The expansion or contraction of these microsatellite regions in tumor as compared to normal tissue is termed “microsatellite instability” and is a characteristic finding in Lynch syndrome as well as in 10-15% of sporadic colon cancers. Some mutations in the MSH2 gene cause a variant of Lynch syndrome called Muir-Torre syndrome. In addition to colorectal cancer, affected individuals may develop rare skin tumors that include sebaceous adenomas and keratoacanthomas.

  • For the diagnosis of Lynch syndrome/hereditary nonpolyposis colorectal cancer
  • Carrier and prenatal screening in families at risk
  • To assist with prognosis and disease management
Any known pathogenic mutation or variant is consistent with a diagnosis of Lynch syndrome. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants.

Negative for mutations analyzed (No pathogenic variant or mutation detected)

Sequence analysis by bidirectional sequence analysis gene-targeted deletion/duplication analysis by quantitative multiplex PCR, long-range PCR, multiplex ligation dependent probe amplification (MLPA).

Whole blood (EDTA).

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: Unacceptable
Array comparative genomic hybridization (aCGH), immunohistochemistry, methylation specific PCR, denaturing high-performance liquid chromatography, H/E stain, Lynch Syndrome genetic panel test, microsatellite instability testing.
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Hum Mutat. 2013;34: 490-7. [PMID: 23255516]
  • JAMA. 2005;293: 799-809. [PMID: 15713769]
  • N Engl J Med. 2003;348: 919-32. [PMID: 12621137]
  • Am J Epidemiol. 2002 Nov 15;156: 885-902. [PMID: 12419761]
  • J Biochem Biophys Methods. 2002;51: 89-100. [PMID: 11879922]
  • Int J Gynecol Pathol. 1992;11: 180-7. [PMID: 1399227]
  • Genetics Home Reference. Available at: https://ghr.nlm.nih.gov/gene/MSH2#
  • GeneReviews® [Internet]. Available at: https://www.ncbi.nlm.nih.gov/books/NBK1211/